Skip to main content

Delays in seeking treatment for symptomatic tuberculosis in Sabah, East Malaysia: factors for patient delay

Buy Article:

$34.78 + tax (Refund Policy)

SETTING: The state of Sabah contributes one third of the tuberculosis (TB) cases in Malaysia.

OBJECTIVE: To collect information on factors that affect the time period from the onset of symptoms to first contact with health care providers, whether private or government.

DESIGN: A cross-sectional study using a pre-tested questionnaire was conducted among 296 newly registered smear-positive TB patients in 10 districts in Sabah. Univariable and multivariable analyses were used to determine which risk factors were associated with patient delay (>30 days) and ‘extreme’ patient delay (>90 days).

RESULTS: The percentage of patients who sought treatment after 30 and 90 days was respectively 51.8% (95%CI 45.7–57.9) and 23.5% (95%CI 18.6–29.0). The strongest factors associated with patient delay and ‘extreme’ patient delay was when the first choice for treatment was a non-government health facility and in 30–39-year-olds. ‘Extreme’ patient delay was also weakly associated, among other factors, with comorbidity and livestock ownership.

CONCLUSION: Delay and extreme delay in seeking treatment were more common when the usual first treatment choice was a non-government health facility. Continuous health education on TB aimed at raising awareness and correcting misconceptions is needed, particularly among those who use non-government facilities.

Keywords: East Malaysia; Sabah; patient delay; tuberculosis

Document Type: Regular Paper

Affiliations: 1: Sabah Health Department, Ministry of Health, Sabah, Malaysia; London School of Hygiene & Tropical Medicine, London, UK 2: London School of Hygiene & Tropical Medicine, London, UK

Publication date: 01 September 2011

More about this publication?
  • The International Journal of Tuberculosis and Lung Disease (IJTLD) is for clinical research and epidemiological studies on lung health, including articles on TB, TB-HIV and respiratory diseases such as COVID-19, asthma, COPD, child lung health and the hazards of tobacco and air pollution. Individuals and institutes can subscribe to the IJTLD online or in print – simply email us at [email protected] for details.

    The IJTLD is dedicated to understanding lung disease and to the dissemination of knowledge leading to better lung health. To allow us to share scientific research as rapidly as possible, the IJTLD is fast-tracking the publication of certain articles as preprints prior to their publication. Read fast-track articles.

  • Editorial Board
  • Information for Authors
  • Subscribe to this Title
  • International Journal of Tuberculosis and Lung Disease
  • Public Health Action
  • Ingenta Connect is not responsible for the content or availability of external websites
  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content